Table 1: Exclusion criteria for eligibility to enroll in the trial.
| Coexisting, untreated urinary stress incontinence Concomitant use of: • Anticholinergic regimens (to cease two weeks prior to treatment and remain off for 6 weeks post treatment) • Anticoagulant or antiplatelet regimens (to cease pre-treatment and resume day 1 post treatment) • Diuretics Dementia Hydronephrosis, post-void residual volume > 100 ml, or another urinary tract anomaly Neurogenic detrusor overactivity Pre-existing voiding abnormalities defined in the urodynamic clinic as either of: • Uroflowmetry parameters (mean and maximal flow rates) < 10 centile for age and gender (Liverpool nomogram) • Post-void residual volumes > 100 ml Pregnancy Surgery for incontinence, vaginal prolapse or hysterectomy within 6 months of recruitment Stroke or other cerebrovascular accident Urinary tract infection Unstable Diabetes |